New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 4, 2014
08:02 EDTSNYGenzyme's Lemtrada approved in Mexico for treatment of MS
Genzyme, a Sanofi company, announced that Mexico’s national regulatory authority, COFEPRIS, has approved Lemtrada for the treatment of patients with relapsing remitting forms of multiple sclerosis to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations.
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
14:03 EDTSNYSanofi initiated with a Buy at HSBC
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use